期刊文献+

慢病毒介导的RNA干扰增殖诱导配体基因抑制胃癌细胞增殖 被引量:2

Lentiviral-mediated knockdown of a proliferation-inducing ligand suppresses proliferation of gastric cancer cell
暂未订购
导出
摘要 目的研究靶向沉默增殖诱导配体(aproliferation-inducing ligand,APRIL)基因对人胃癌MGC803细胞增殖及细胞周期的影响。方法构建含有APRIL的siRNA序列的慢病毒载体并转染人胃癌MGC803细胞,以非特异性序列nonsilencing siRNA作为对照。通过Real-time PCR(RT-PCR)评价APRIL的沉默效率;MTT法检测沉默A-PRIL基因后,细胞增殖的变化;流式细胞仪检测细胞周期的变化。结果 RT-PCR测序证实,成功构建APRIL siR-NA慢病毒表达载体;与非特异性序列载体转染组相比,RT-PCR证实APRIL在慢病毒转染的细胞中表达显著降低(P<0.05);APRIL siRNA慢病毒载体转染后的MGC803细胞,细胞增殖显著降低,细胞周期被阻滞在G2/M期。结论靶向APRIL基因的慢病毒表达载体在体外能明显抑制人胃癌MGC803细胞的生长,为其在胃癌发病机制研究奠定了实验基础。 Objective To investigate the effects of a proliferation-inducing ligand(APRIL) gene silencing on cell proliferation and cell cycle of gastric cancer cell line(MGC803).Methods Lentivirus containing siRNA sequence of APRIL was constructed,and infected the human gastric cancer MGC803 cells with nonspecific(NS) siRNA sequence as a control.APRIL mRNA expression was examined by real-time quantitative PCR(RT-PCR);MTT assay was used to study the effects ofknockdown of APRIL in cell proliferation;cell cycle analysis was detected by flow cytometry.Results The results of sequencing demonstrated that the RNAi sequence targeting APRIL gene was successfully inserted into the lentiviral vector.Compared with non-specific sequence plasmid,the results of RT-PCR confirmed that expression of APRIL was much lower in APRIL-siRNA-transfected cells.(P 0.05).Infected MGC803 cells with APRIL siRNA lentiviral vector,cell viability was significantly hindered,cell cycle arrested in G2/M phase.Conclusion Lentivirus containing siRNA targeting APRIL gene can inhibit the growth of human gastric cancer MGC803 cells in vitro and this lays a basis on the study of its pathogenesis in the gastric cancer.
出处 《中国实验诊断学》 2012年第12期2166-2169,共4页 Chinese Journal of Laboratory Diagnosis
基金 国家青年自然基金(30901702) 吉林省中青年领导人才创新团队项目(20111807) 吉林大学杰出青年基金(201005001)
关键词 增殖诱导配体 RNA干扰 胃癌 细胞增殖 细胞周期 a proliferation-inducing ligand RNA interfering gastric cancer cell proliferation cell cycle
  • 相关文献

参考文献11

  • 1Hahne M,Kataoka J , Schroter M, et al. APRII., a new ligand ot the tumor necrosis factor family, stimulates tumor cell growth [J].J Exp Med,1998,188(6) : 1185.
  • 2Yaccoby S, Pennisi A, Li X, et al. Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SClD-hu mice and in coculture with osteoclasts[J]. Leukemia, 2008,22 (2) 409.
  • 3Kelly K,Manos E,Jensen G,et al. APRIL/TRDL-1 ,a tumor nec rosis factor like ligand, stimulates cell death[J]. Cancer Res, 2000,60(4) :1026.
  • 4Resende C, Ristimaki A, Machado JC. Genetic and epigenetic al- teration in gastric carcinogenesis[J]. Helicobacter, 2010,15 (1) 35.
  • 5Chiu A, Xu W, He B, et al. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and prolifera tion signals in response to BAFF and APR1L[J]. Blood, 2007,109 (2):737.
  • 6Chu VT,Enghard P,Riemekasten G,et al. In vitro and in vivo ac- Livation induces BAFF and APRIL expression in B eells[J]. J Im- munol, 2007,179(9) : 5956.
  • 7Mhawech-Fauceglia P, AIIaA1, Odunsi K, et al. Role of the tumour necrosis family ligand APRIL in solid tumour develop- ment :Retrospective studies in bladder,ovarian and head and neck careinomas[J].European journal of cancer, 2008,44 ( 15 ) : 2099.
  • 8Wang F,Ding W, Wang J, et al. Identification of microRNA tar- get interaction in APRIl. knockdown colorectal cancer cells[J].Cancer Gene Therapy,2011,18(7) :507.
  • 9Roosnek E, Burjanadze M, Dietrich PY, et al. Tumors that look for their springtime in APRIL[J]. Crit Rev Oncol Hematol, 2009,72(2) :95.
  • 10Romano G. Current development of lentivial-mediated gene transfer[ J]. Drug News Perspect, 2005,18(2) : 132.

同被引文献23

  • 1Yan Y, Zhang J, Guo JL, et al. Multiple shRNA-mediated knockdown of TACE reduces the Malignancy of HeLa cells [J]. Cell Biol Int, 2009, 33(2) :158 -164.
  • 2Mhawech-Fauceglia P, Kaya G, Sauter G, et al. The source of APRIL up-regulation in human solid tumor lesions[ J]. J Leu- koc Biol, 2006, 80(4):697 -704.
  • 3Reynolds A, Leake D , Boese Q, et al. Rational siRNA design for RNA interference[ J]. Nat Biotechnol, 2004, 22 (3): 326 -330.
  • 4Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Chn, 2011,61(2) :69 -90.
  • 5Townsend MJ, Monroe JG, Chan AC. B-cell targeted therapiesin human autoimmune diseases:an updated perspective[J]. Im- munoi Rev, 2010, 237(12) : 264-283.
  • 6Sun B, Wang H, Wang X, et al. A proliferation-inducing ligand : a new biomarker for non-small cell lung cancer[ J]. Exp Lung Res, 2009, 35 ( 12 ) :4436 - 4500.
  • 7Migita K, Ilyassova B, Kovzel EF, et al. Serum BAFF and APRIL levels in Datients with PBC[J]. Clin Immunol, 2010, 134 (2) : 217 225.
  • 8Rodriguez-Berriguete G, Galvis L, Fraile B, et al. Immunoreactivi- ty to caspase-3, caspase-7, easpase-8, and caspase-9 forms is fre- quently lost in human prostate tumor [J]. Hum Pathol, 2012, 43(2) .. 229-237.
  • 9樊勇军,冯一中,李海,郑晓娟.Survivin、caspase-3及AKT1在大肠癌中的表达及意义[J].实用癌症杂志,2010,25(1):26-30. 被引量:12
  • 10王敬春,王惠民,丁伟峰,黄华,孙宝兰,景蓉蓉.靶向增殖诱导配体的RNA干扰对人结直肠癌裸鼠移植瘤的影响[J].中华实验外科杂志,2010,27(4):465-467. 被引量:6

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部